CORRECT Study of Minimal Residual Disease Detection in Colorectal Cancer
Public ClinicalTrials.gov record NCT05210283. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
CORRECT-MRD II: Second Colorectal Cancer Clinical Validation Study to Predict Recurrence Using a Circulating Tumor DNA Assay to Detect Minimal Residual Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The CORRECT - MRD II study will prospectively enroll patients who have undergone complete surgical resection for stage II or III colorectal cancer. Maximum duration of participant participation is up to seven years from enrollment to study completion with up to five years of active follow up and up to two years of clinical (passive) follow up.
Study identification
- NCT ID
- NCT05210283
- Recruitment status
- Active, not recruiting
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 1,017 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 15, 2021 (Actual)
- Primary completion
- May 15, 2027 (Estimated)
- Completion
- May 15, 2027 (Estimated)
- Last update posted
- Jan 12, 2026
2021 – 2027
United States locations
- U.S. sites
- 28
- U.S. states
- 17
- U.S. cities
- 28
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Facey Medical Group - Mission Hills - Endoscopy Center & Gastroenterology | Mission Hills | California | 91345 | — |
| Torrance Memorial Hunt Cancer Institute | Torrance | California | 90505 | — |
| University of Florida Division of Hematology & Oncology | Gainesville | Florida | 32610 | — |
| Mount Sinai Medical - Comprehensive Cancer Center | Miami Beach | Florida | 33140 | — |
| Mid Florida Cancer Centers | Orange City | Florida | 32763 | — |
| Edward Cancer Center | Elmhurst | Illinois | 60126 | — |
| Illinois Cancer Care | Peoria | Illinois | 61615 | — |
| Mercy Medical Center | Cedar Rapids | Iowa | 52403 | — |
| University of Kansas Cancer Center | Westwood | Kansas | 66205 | — |
| MedStar Georgetown Cancer Institute at MedStar Georgetown University Hospital | Baltimore | Maryland | 21237 | — |
| Meritus Center for Clinical Research | Hagerstown | Maryland | 21742 | — |
| University of Maryland St. Joseph Medical Center | Towson | Maryland | 21093 | — |
| Metro Minnesota Community Oncology Consortium (MMCORC) | Saint Louis Park | Minnesota | 55426 | — |
| Missouri Baptist Medical Center | St Louis | Missouri | 63131 | — |
| Atrium Health Levine Cancer Institute | Charlotte | North Carolina | 28204 | — |
| FirstHealth Outpatient Cancer Center | Pinehurst | North Carolina | 28374 | — |
| Atrium Health Wake Forest Baptist Medical Center | Winston-Salem | North Carolina | 27157 | — |
| Sanford Roger Maris Cancer Center | Fargo | North Dakota | 58104 | — |
| Columbus NCORP | Columbus | Ohio | 43215 | — |
| Interstate Medical Office Central | Portland | Oregon | 97227 | — |
| UPMC Hillman Cancer Center | Pittsburgh | Pennsylvania | 15232 | — |
| Reading Hospital Hematology Oncology | West Reading | Pennsylvania | 19611 | — |
| Lankenau Medical Center | Wynnewood | Pennsylvania | 19096 | — |
| WellSpan York Cancer Center | York | Pennsylvania | 17403 | — |
| Primsa Health Cancer Institute | Greenville | South Carolina | 29605 | — |
| Sanford Cancer Center | Sioux Falls | South Dakota | 57104 | — |
| Ballad Health Cancer Center | Kingsport | Tennessee | 37660 | — |
| Marshfield Medical Center Weston | Weston | Wisconsin | 54476 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05210283, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 12, 2026 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05210283 live on ClinicalTrials.gov.